Curran Simpson, Chief Oper. & Technology Officer at REGENXBIO Inc. (RGNX), sold 24,924 shares at $50.03 ($1.2M) on 2021-01-12, disclosed to the SEC on 2021-01-14.
Open-market sale of $1.2M RGNX by Chief Oper. & Technology Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $50.03 | 1,700 | $85K | 6.8% |
| 2 | $50.01 | 11,612 | $581K | 46.6% |
| 3 | $50.01 | 11,612 | $581K | 46.6% |
| Total | $50.01 avg | 24,924 | $1.2M | 100% |
| Filing → |
| RGNX | SELL | 2025-09-12 | $155K | — | Filing → |
| RGNX | SELL | 2024-08-05 | $2K | — | Filing → |
| RGNX | SELL | 2024-07-30 | $290K | — | Filing → |